Igs2em8(KRT14-icre)Gpt
Endonuclease-mediated Allele Detail
|
Symbol: |
Igs2em8(KRT14-icre)Gpt |
Name: |
intergenic site 2; endonuclease-mediated mutation 8, GemPharmatech Co., Ltd |
MGI ID: |
MGI:6718926 |
Synonyms: |
H11em1Cin(hKRT14-iCre), H11-hKRT14-iCre, keratin14-Cre |
Gene: |
Igs2 Location: unknown Genetic Position: Chr11, Syntenic
|
Alliance: |
Igs2em8(KRT14-icre)Gpt page
|
|
|
Allele Type: |
|
Endonuclease-mediated (Recombinase) |
Mutation: |
|
Insertion
|
|
|
Igs2em8(KRT14-icre)Gpt expression driven by
1 gene
Knock-in expression driven by:
Organism |
Driver Gene |
Homolog in Mouse |
Note |
human |
KRT14 (3861) |
|
|
|
|
|
Mutation details: CRISPR-targeting introduced an icre driven by human KRT14 enhancer and promoter into Igs2 H11 docking site.
(J:293217)
|
|
|
Activity: |
Tissue activity of this recombinase allele
|
Driver:
|
KRT14
(human)
|
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Igs2 Mutation: |
68 strains or lines available
|
|
Original: |
J:306959 Qu H, et al., Dedicator of Cytokinesis 5 Regulates Keratinocyte Function and Promotes Diabetic Wound Healing. Diabetes. 2021 May;70(5):1170-1184 |
All: |
2 reference(s) |
|